Unleashing the power of digital pathology and AI for precision medicine
Posted 2nd October 2019 by Joshua Sewell
We’re looking back at the highlights from the Digital Pathology and AI meeting in 2018 as we anticipate this year’s Digital Pathology and AI Congress in December. This second post in our mini-series reviews Marylin Bui’s keynote presentation where she explained how the combination of Digital Pathology and Artificial Intelligence (AI) holds huge potential for patient care.
Lab Data Automation, Optimizing R&D Workflows and Lead Discovery from Biologically Complex Bioassays
Posted 23rd January 2019 by Jane Williams
With an increasing amount of data being generated today, pharma and biotech companies need to develop new technologies and strategies in order to structure, analyse and integrate this big data. If you weren’t able to attend our Global Pharma R&D Informatics & AI Congress, we have made these slides from Ralph Haffner, Dana Caulder and Pierre Farmer available.
Synthetic Biology: Miniaturisation for Automation
Posted 22nd November 2017 by Jane Williams
Synthetic biology holds much promise. Researchers have been working toward using techniques to create new valuable products such as novel therapeutics and drugs, biorenewable fuels, and new biochemicals and biomaterials. It requires a multidisciplinary effort – it calls for biologists, chemists, engineers, software developers (STEM disciplines) to collaborate on finding ways to understand how genetic parts work together, and then combine them to produce useful applications.